Artificial intelligence–enabled assessment of the heart rate corrected QT interval using a mobile electrocardiogram device

JR Giudicessi, M Schram, JM Bos, CD Galloway… - Circulation, 2021 - Am Heart Assoc
Background: Heart rate–corrected QT interval (QTc) prolongation, whether secondary to
drugs, genetics including congenital long QT syndrome, and/or systemic diseases including …

[HTML][HTML] Applications of machine learning in cardiac electrophysiology

RG Muthalaly, RM Evans - Arrhythmia & Electrophysiology Review, 2020 - ncbi.nlm.nih.gov
Artificial intelligence through machine learning (ML) methods is becoming prevalent
throughout the world, with increasing adoption in healthcare. Improvements in technology …

Wireless monitoring devices in hospitalized children: a scoping review

E Senechal, E Jeanne, L Tao, R Kearney… - European Journal of …, 2023 - Springer
The purpose of this study is to provide a structured overview of existing wireless monitoring
technologies for hospitalized children. A systematic search of the literature published after …

Risk of QTc prolongation among cancer patients treated with tyrosine kinase inhibitors

AA Abu Rmilah, G Lin, KH Begna… - … journal of cancer, 2020 - Wiley Online Library
QTc interval prolongation can lead to life‐threatening complications such as Torsade de
Pointes (TdP), ventricular tachycardia (VT) and sudden cardiac death (SCD). It can occur …

Feasibility and safety of intravenous sotalol loading in adult patients with atrial fibrillation (DASH-AF)

D Lakkireddy, A Ahmed, D Atkins, D Bawa, J Garg… - Clinical …, 2023 - jacc.org
Background Inpatient initiation of sotalol is recommended owing to its proarrhythmic effects.
Objectives The DASH-AF (Feasibility and Safety of Intravenous Sotalol Administered as a …

Manual QT interval measurement with a smartphone-operated single-lead ECG versus 12-lead ECG: a within-patient diagnostic validation study in primary care

L Beers, LP van Adrichem, JCL Himmelreich… - BMJ open, 2021 - bmjopen.bmj.com
Objective To determine the accuracy of QT measurement in a smartphone-operated, single-
lead ECG (1L-ECG) device (AliveCor KardiaMobile 1L). Design Cross-sectional, within …

[HTML][HTML] Corrected QT interval (QTc) diagnostic app for the oncological routine: development study

K Klier, YJ Patel, T Schinköthe, N Harbeck, A Schmidt - JMIR cardio, 2023 - cardio.jmir.org
Background: Numerous antineoplastic drugs such as chemotherapeutics have cardiotoxic
side effects and can lead to long QT syndrome (LQTS). When diagnosed and treated in time …

State of the art of mobile health technologies use in clinical arrhythmia care

AR Sridhar, JW Cheung, R Lampert, JNA Silva… - Communications …, 2024 - nature.com
The rapid growth in consumer-facing mobile and sensor technologies has created
tremendous opportunities for patient-driven personalized health management. The …

[HTML][HTML] KardiaMobile 6L for measuring QT interval in people having antipsychotic medication to inform early value assessment: a systematic review.

M Westwood, N Armstrong, P Posadzki… - Health Technology …, 2024 - ncbi.nlm.nih.gov
BACKGROUND The indication for this assessment is the use of the KardiaMobile six-lead
electrocardiogram device for the assessment of QT interval-based cardiac risk in service …

Comparison of AliveCor KardiaMobile Six-Lead ECG with standard ECG in pediatric patients

ZP Girvin, ES Silver, L Liberman - Pediatric Cardiology, 2023 - Springer
Abstract The AliveCor KardiaMobile (ACKM) is a remote electrocardiogram (ECG)
monitoring device. Little research has been conducted on its accuracy with pediatric …